RGNX stock analysis: momentum, squeeze and dilution
MonScreener's historical stock analysis for RGNX, using the latest stored scan snapshot. Review the recorded momentum score, float and volume data, short-pressure fields and SEC dilution context that were available on that date.
- Snapshot price
- $8.18
- Snapshot session change
- -23.69%
- Sector
- Healthcare
- Market capitalization
- 539.99M
- Session volume
- 693,573
- Float
- 57.34M
- MonScreener score
- 16/100 · grade D
- Risk band
- Medium
- Short float
- 10.90%
- Days to cover
- 3.79
- Dilution risk
- MEDIUM
- SEC filing warning
- Present
- Snapshot date
- 2026-08-24
- Data source
- historical snapshot
Historical scan snapshot timestamp: 2026-08-24. Snapshot values can be stale or incomplete; the interactive stock analysis loads separately.
Momentum score and grade
The stored snapshot scored RGNX at 16/100 with a D grade. The score combines available momentum, float, volume, catalyst, squeeze and dilution inputs. It is a research ranking, not a recommendation or forecast.
Short-squeeze and borrow context
Available fields in this snapshot include short float 10.90%, 3.79 days to cover. These values can change quickly and may come from delayed or limited provider coverage. Compare them with float, liquidity, a verifiable catalyst and current broker data. Learn how MonScreener evaluates squeeze candidates.
SEC dilution context
The stored snapshot included an SEC filing warning. Automated filing signals can miss or misread terms, so confirm the latest primary filing before acting. Read the SEC dilution research guide.
Explore: Stock Screener · Prediction Track Record · MonScreener home